The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
Carver
Brett S
BS
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. carverb@mskcc.org
Cronin
Angel M
AM
Eggener
Scott
S
Savage
Caroline J
CJ
Motzer
Robert J
RJ
Bajorin
Dean
D
Bosl
George J
GJ
Sheinfeld
Joel
J
D000328:Adult; D001707:Biopsy, Needle; D017024:Chemotherapy, Adjuvant; D015331:Cohort Studies; D016208:Databases, Factual; D005355:Fibrosis / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery; D006801:Humans; D007150:Immunohistochemistry; D016014:Linear Models; D008197:Lymph Node Excision / Q000379:methods*; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008297:Male; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D009919:Orchiectomy / Q000379:methods; D011336:Probability; D011379:Prognosis; D016016:Proportional Hazards Models; D012187:Retroperitoneal Space; D012189:Retrospective Studies; D018570:Risk Assessment; D016019:Survival Analysis; D013724:Teratoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000556:secondary* / Q000601:surgery*; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D016896:Treatment Outcome; D055815:Young Adult